Piece of Opinion: America Faces a Decisive Test: How Long Will Lebanon Remain an Open Battleground?
 
Wonder 64: A Mother’s Healing Through the Intercession of Saint Charbel
 
The Surprise Only Our Leaders Didn’t See Coming
 
Dr. Rateb Jneid: "On the National Apology Day, we salute the strength, dignity, and resilience of the peoples of First Nations.
 
For the attention of the Maronite leaderships!
 
Sister Noel Marie Sleiman Saadeh passed away
 
With grief and sadness, the President of the (LONC) and all Lebanese mourn the hero commander, Dean Alrakin Youssef Al-Tahan
 
A Submission to the Royal Commission on Antisemitism and Social Cohesion
 
Hormuz faces a dangerous global precedent: Will it open the door for China to repeat the scenario in Taiwan?
 
President Joseph Aoun: “Eid al-Adha teaches us not to sacrifice our children or shed their blood”
 
Now is the Time
 
Natalie Ward raised her voice regarding electric bike license plates as, after six months, nothing has been done!
 
Fresh hope for diabetics





Fresh hope for diabetics

February 6, 2010 

The UAE health care budget annual spending on treating the disease is between Dh367 and Dh734 million. Image Credit: Supplied London: Scientists have used an "artificial pancreas" system of pumps and monitors to improve blood sugar control in diabetes patients in the first study to show the new device works better than conventional treatment.

Researchers from Britain's Cambridge University tested the device on 17 children with type 1 diabetes during a series of nights in hospital and found it kept their blood sugar levels within the "normal" range 60 per cent of the time.

The new system, which involves patients wearing a matchbox-sized monitor and a similar-sized pump with a tube to deliver insulin into the body, also halved the amount of time blood sugar dropped to worrying or dangerous levels, they said.

Medical device makers have been working for years to develop a so-called artificial pancreas to deliver insulin to patients with type 1 diabetes, an autoimmune disease in which the body destroys its own ability to make insulin.

 

The bodies of type 1 diabetes sufferers become unable to properly break down sugar and if untreated, blood vessels and nerves are destroyed, organs fail and patients die.

"These devices could transform the management of type 1 diabetes, but it is likely to be a gradual process," Roman Hovorka of Cambridge, who led the research, said in a telephone interview.

He said the results were "an important stepping stone" towards bringing an artificial pancreas to the commercial market, but predicted several years yet of refinement before it could be used day and night by patients.

"It's a bit like with mobile phones. When we started, the technology wasn't very good and the functionality was limited, and it took a number of generations to move to the device that we have now. I see the same thing with this system."

24-hour checks

The oal is to create a device that can check patients' blood day and night.

The Cambridge study found their device performed better than a conventional pump, which delivers insulin at pre-set rates and which kept blood sugar levels around normal for 40 per cent of the time compared with 60 per cent for the artificial pancreas.

Hovorka said the findings were particularly encouraging because the study included nights when the children went to bed after eating a large evening meal or having done exercise — both of which can affect blood sugar levels.

 


 














Copyright 2007 mideast-times.com